Vaccine Development

Clinical Trials mRNA Technology COVID-19 Vaccines mRNA Vaccines Regulatory Approval Safety and Efficacy Vaccine Research Research Funding Advisory Committees Pharmaceutical Companies Emergency Use Authorization Vaccine Safety Biotechnology Ebola Vaccines Covid-19 Vaccines RNA Technology Immunology Vaccine Effectiveness Manufacturing Capacity Manufacturing Regulatory Agencies Immunization Public Health Immunization Programs Chikungunya Virus Vaccine Hubs FDA Regulations Global Health Initiatives Vaccine Production Vaccine Supply COVID-19 Regulatory Bodies

Engineered mRNA Nanoparticles Reroute Delivery to Lymph Nodes in Mouse Study

The Penn design cuts liver exposure about tenfold to support lower-dose, better-tolerated mRNA vaccines.

AI Pinpoints Single-Protein Mpox Target That Elicits Neutralizing Antibodies in Mice

Florida Starts Process to Drop Four School Vaccine Requirements

HHS Withdraws $766 Million for Moderna’s Bird Flu mRNA Vaccine